Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's disease

Zhang, Wei, Wang, Tongguang, Pei, Zhong, Miller, David S., Wu, Xuefei, Block, Michelle L., Wilson, Belinda, Zhang, Wanqin +3 more·2005·The FASEB Journal

Cited by (1,000)

Items 401–500 of 1,000

  1. Proteolytic Cleavage of Extracellular α-Synuclein by Plasmin
    Kwang Soo Kim, Yu Ree Choi, Ji Young Park, Jung-Ho Lee, Dong Kyu Kim, Seung‐Jae Lee, Seung R. Paik, Ilo Jou, Sang Myun Park · 2012 · Journal of Biological Chemistry
  2. Role of Microglia Adenosine A2AReceptors in Retinal and Brain Neurodegenerative Diseases
    Ana Raquel Santiago, Filipa I. Baptista, Paulo F. Santos, Gonçalo Cristóvão, António Francisco Ambrósio, Rodrigo Antunes Cunha, Catarina A. Gomes · 2014 · Mediators of Inflammation
  3. Modulation of Microglial Activity by Rho-Kinase (ROCK) Inhibition as Therapeutic Strategy in Parkinson’s Disease and Amyotrophic Lateral Sclerosis
    Roser, Anna-Elisa, Tönges, Lars, Lingor, Paul · 2017 · Frontiers in Aging Neuroscience
  4. 3‐Hydroxymorphinan, a metabolite of dextromethorphan, protects nigrostriatal pathway against MPTP‐elicited damage both in vivo and in vitro
    Wei Zhang, Eun‐Joo Shin, Tongguang Wang, Phil Ho Lee, Hao Pang, Myung‐Bok Wie, Won‐Ki Kim, Seong‐Jin Kim, Wen‐Hsin Huang, Yongjun Wang et al. · 2006 · The FASEB Journal
  5. CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease
    Yuanyuan Li, Mengyue Niu, Aonan Zhao, Wenyan Kang, Zhichun Chen, Ningdi Luo, Liche Zhou, Xiongwei Zhu, Liming Lu, Jun Liu · 2019 · Journal of Neuroinflammation
  6. Novel role of aquaporin-4 in CD4+ CD25+ T regulatory cell development and severity of Parkinson’s disease
    Ying Chi, Yi Fan, Lei He, Wei Yong Liu, Xiaoyun Wen, Sha Zhou, Xuefeng Wang, Cui Zhang, Hui Kong, Laura Sonoda et al. · 2011 · Aging Cell
  7. Microglial activation in brain lesions with tau deposits: Comparison of human tauopathies and tau transgenic mice TgTauP301L
    Atsushi Sasaki, Takeshi Kawarabayashi, Tetsuro Murakami, Etsuro Matsubara, Masaki Ikeda, Haruo Hagiwara, David A. Westaway, Peter St George‐Hyslop, Mikio Shoji, Yoichi Nakazato · 2008 · Brain Research
  8. Protein oxidation and degradation during aging: Role in skin aging and neurodegeneration
    Rebecca Widmer, Isabella Ziaja, Tilman Grune · 2006 · Free Radical Research
  9. Mechanisms of alpha-synuclein toxicity: An update and outlook
    Inês Caldeira Brás, Mary Xylaki, Tiago F. Outeiro · 2019 · Progress in brain research
  10. Peripheral Immunity, Immunoaging and Neuroinflammation in Parkinson’s Disease
    Nataša Z. Kuštrimović, Franca Marino, Marco Cosentino · 2018 · Current Medicinal Chemistry
  11. Neuroprotection of Rotenone-Induced Parkinsonism by Ursolic Acid in PD Mouse Model
    Walia Zahra, Sachchida Nand, Hareram Birla, Saumitra Sen Singh, Aaina Singh Rathore, Hagera Dilnashin, Richa Singh, Chetan Keswani, Rakesh Kumar Singh, Surya Pratap Singh · 2020 · CNS & Neurological Disorders - Drug Targets
  12. PARK7/DJ-1 in microglia: implications in Parkinson’s disease and relevance as a therapeutic target
    Frida Lind‐Holm Mogensen, Andrea Scafidi, Aurélie Poli, Alessandro Michelucci · 2023 · Journal of Neuroinflammation
  13. Identification of Proteins Involved in Microglial Endocytosis of α-Synuclein
    Jun Liu, Yong Feng Zhou, Yan Wang, Hanson K. Fong, Thomas M. Murray, Jing Zhang · 2007 · Journal of Proteome Research
  14. Iron-enhanced paraquat-mediated dopaminergic cell death due to increased oxidative stress as a consequence of microglial activation
    Jun Peng, Fang Feng Stevenson, May Lin Oo, Julie Kay Andersen · 2008 · Free Radical Biology and Medicine
  15. Abnormal alpha-synuclein reduces nigral voltage-dependent anion channel 1 in sporadic and experimental Parkinson's disease
    Yaping Chu, Jennifer G. Goldman, Leo P. Kelly, Yinzhen He, Tracy Waliczek, Jeffrey H. Kordower · 2014 · Neurobiology of Disease
  16. Role of neurotoxicants and traumatic brain injury in α-synuclein protein misfolding and aggregation
    Dharmin Rokad, Shivani Ghaisas, Dilshan S. Harischandra, Huajun Jin, Vellareddy Anantharam, Arthi Kanthasamy, Anumantha G. Kanthasamy · 2016 · Brain Research Bulletin
  17. Alpha-synuclein oligomers impair memory through glial cell activation and via Toll-like receptor 2
    Pietro La Vitola, Claudia Balducci, Milica Cerovic, Giulia Santamaria, Edoardo Brandi, Federica Grandi, Laura Caldinelli, Laura Colombo, Maria Grazia Morgese, Luigia Trabace et al. · 2018 · Brain Behavior and Immunity
  18. Endocytotic uptake of iron oxide nanoparticles by cultured brain microglial cells
    Eva M. Luther, Charlotte Petters, Felix Bulcke, Achim Kaltz, Karsten Thiel, Ulf Bickmeyer, Ralf Dringen · 2013 · Acta Biomaterialia
  19. The Relevance of Iron in the Pathogenesis of Multiple System Atrophy: A Viewpoint
    Christine Kaindlstorfer, K. A. Jellinger, Sabine Eschlböck, Nadia Stefanova, Günter Weiß, Gregor Karl Wenning · 2018 · Journal of Alzheimer s Disease
  20. Intranasal PRGF-Endoret enhances neuronal survival and attenuates NF-κB-dependent inflammation process in a mouse model of Parkinson's disease
    Eduardo Anitua, Consuelo Pascual, Rocío Pérez‐González, Gorka Orive, Eva Carro · 2015 · Journal of Controlled Release
  21. Iminosugar-Based Inhibitors of Glucosylceramide Synthase Increase Brain Glycosphingolipids and Survival in a Mouse Model of Sandhoff Disease
    Karen M. Ashe, Dinesh S. Bangari, Lingyun Li, Mario A. Cabrera-Salazar, Scott D. Bercury, Jennifer B. Nietupski, Christopher G. F. Cooper, Johannes M. F. G. Aerts, Edward R. Lee, Diane Copeland et al. · 2011 · PLoS ONE
  22. Genetically engineered mouse models of Parkinson's disease
    Donna Crabtree, Jianhua Zhang · 2011 · Brain Research Bulletin
  23. Neuroinflammation and Glial Phenotypic Changes in Alpha-Synucleinopathies
    Violetta Refolo, Nadia Stefanova · 2019 · Frontiers in Cellular Neuroscience
  24. Fine mapping of the HLA locus in Parkinson’s disease in Europeans
    Eric Yu, Aditya Ambati, Maren Stolp Andersen, Lynne Krohn, Mehrdad A. Estiar, Prabhjyot Saini, Konstantin A. Senkevich, Yuri Ludwig Sosero, Ashwin Ashok Kumar Sreelatha, Jennifer A. Ruskey et al. · 2021 · npj Parkinson s Disease
  25. Apoptosis Signal-Regulating Kinase 1 Mediates MPTP Toxicity and Regulates Glial Activation
    Kang-Woo Lee, Xin Zhao, Joo‐Young Im, Hilary Grosso, Won Hee Jang, Teresa W. Chan, Patricia K. Sonsalla, Dwight C. German, Hidenori Ichijo, Eunsung Junn et al. · 2012 · PLoS ONE
  26. Transcriptome analysis of LRRK2 knock-out microglia cells reveals alterations of inflammatory- and oxidative stress-related pathways upon treatment with α-synuclein fibrils
    Isabella Russo, Alice Kaganovich, Jinhui Ding, Natalie Landeck, Adamantios Mamais, Tatiana Varanita, Alice Biosa, Isabella Tessari, Luigi Bubacco, Elisa Greggio et al. · 2019 · Neurobiology of Disease
  27. α‐Synuclein mediates alterations in membrane conductance: a potential role for α‐synuclein oligomers in cell vulnerability
    Li Feng, Howard J. Federoff, Stefano Vicini, Kathleen A. Maguire‐Zeiss · 2010 · European Journal of Neuroscience
  28. The Prion Hypothesis of Parkinson’s Disease
    Yaping Chu, Jeffrey H. Kordower · 2015 · Current Neurology and Neuroscience Reports
  29. Inflammation and neurodegeneration: the story ‘retolled’
    Janelle Drouin‐Ouellet, Francesca Cicchetti · 2012 · Trends in Pharmacological Sciences
  30. Tyrosine Kinase Inhibition Regulates Early Systemic Immune Changes and Modulates the Neuroimmune Response in α-Synucleinopathy
    M. Hebron, I. Lonskaya, Paul Olopade, S. Selby, F. Pagán, C. Moussa · 2014 · Journal of Clinical & Cellular Immunology
  31. Single-Molecule Characterization of the Interactions between Extracellular Chaperones and Toxic α-Synuclein Oligomers
    Daniel R. Whiten, Dezerae Cox, Mathew H. Horrocks, Christopher G. Taylor, Suman De, Patrick Flagmeier, Laura Tosatto, Janet R. Kumita, Heath W. Ecroyd, Christopher Martin Dobson et al. · 2018 · Cell Reports
  32. Long-term polarization of microglia upon α-synuclein overexpression in nonhuman primates
    Pernille Barkholt, Vanesa Sánchez-Guajardo, Deniz Kirik, Marina Romero‐Ramos · 2012 · Neuroscience
  33. Microglial memory of early life stress and inflammation: Susceptibility to neurodegeneration in adulthood
    Paula Desplats, Ashley M. Gutierrez, Marta Cristina Antonelli, Martin Gerbert Frasch · 2019 · Neuroscience & Biobehavioral Reviews
  34. The Role of Glia in Alpha-Synucleinopathies
    Lisa Fellner, Nadia Stefanova · 2012 · Molecular Neurobiology
  35. Clues to how alpha‐synuclein damages neurons in Parkinson's disease
    David L. Sulzer · 2010 · Movement Disorders
  36. Targeting intracellular and extracellular alpha-synuclein as a therapeutic strategy in Parkinson's disease and other synucleinopathies
    Kostas Vekrellis, Leonidas Stefanis · 2012 · Expert Opinion on Therapeutic Targets
  37. Neuroinflammation in Parkinson’s patients and MPTP-treated mice is not restricted to the nigrostriatal system: Microgliosis and differential expression of interleukin-1 receptors in the olfactory bulb
    Anne Vroon, Benjamin Drukarch, John G. J. M. Bol, Patrick P Cras, John J. P. Brevé, Stuart McRae Allan, Jane K. Relton, Piet V.J.M. Hoogland, Anne‐Marie van Dam · 2007 · Experimental Gerontology
  38. A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson’s disease-like pathology in neurons and glia
    Martin T. Henrich, Fanni F. Geibl, Bolam Lee, Wei‐Hua Chiu, James B. Koprich, Jonathan M. Brotchie, Lars Timmermann, Niels Decher, Lina A. Matschke, Wolfgang Hermann Oertel · 2018 · Acta Neuropathologica Communications
  39. Superoxide Radical Dismutation as New Therapeutic Strategy in Parkinson’s Disease
    Federica De Lazzari, Luigi Bubacco, Alexander J. Whitworth, Marco Bisaglia · 2018 · Aging and Disease
  40. Glial cells involvement in spinal muscular atrophy: Could SMA be a neuroinflammatory disease?
    Elena Abati, Gaia Citterio, Nereo Bresolin, Giacomo P. Comi, Stefania Paola Corti · 2020 · Neurobiology of Disease
  41. Epigenetic Changes and Its Intervention in Age-Related Neurodegenerative Diseases
    Nuraqila Mohd Murshid, Faridah Aminullah Lubis, Suzana Makpol · 2020 · Cellular and Molecular Neurobiology
  42. Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson’s disease
    Elvira Valera, Michael Mante, Scott Anderson, Edward M. Rockenstein, Eliezer Masliah · 2015 · Journal of Neuroinflammation
  43. Oxidative stress-dependent changes in immune responses and cell death in the substantia nigra after ozone exposure in rat
    Selva Rivas-Arancibia, Luis Fernando Hernández-Zimbrón, Erika Rodrı́guez-Martı́nez, Perla D. Maldonado, Gabino Borgonio-Pérez, María Sepúlveda-Parada · 2015 · Frontiers in Aging Neuroscience
  44. Parkinson's disease: Microglial/macrophage-induced immunoexcitotoxicity as a central mechanism of neurodegeneration
    Russell L. Blaylock · 2017 · Surgical Neurology International
  45. High expression of the HMGB1–TLR4 axis and its downstream signaling factors in patients with Parkinson's disease and the relationship of pathological staging
    Yi Yang, Chenyang Han, Li Guo, Qiaobin Guan · 2018 · Brain and Behavior
  46. Recent progress in therapeutic strategies for microglia-mediated neuroinflammation in neuropathologies
    Neelima Gupta, Sukanya Shyamasundar, Radhika Patnala, Aparna Karthikeyan, Thiruma Valavan Arumugam, Eng‐Ang Ling, Shaikali Thameem Dheen · 2018 · Expert Opinion on Therapeutic Targets
  47. Translocator Protein Ligand Protects against Neurodegeneration in the MPTP Mouse Model of Parkinsonism
    Jing Gong, Éva M. Szegő, Andrei Leonov, Eva Benito, Stefan Becker, André Fischer, Markus Zweckstetter, Tiago F. Outeiro, Anja Schneider · 2019 · Journal of Neuroscience
  48. Modulation of Glial Function in Health, Aging, and Neurodegenerative Disease
    Kendra L. Hanslik, Kaitlyn M. Marino, Tyler Kent Ulland · 2021 · Frontiers in Cellular Neuroscience
  49. Microglia and astrocyte activation is region‐dependent in the α‐synuclein mouse model of Parkinson's disease
    Leyre Basurco, Miguel Angel Abellanas, Leyre Ayerra, Enrique Conde, Rodrigo Vinueza‐Gavilanes, Esther Luquin, África Vales, Amaya Vilas, Patxi San Martín‐Úriz, Ibón Tamayo et al. · 2022 · Glia
  50. Gene expression changes in postmortem tissue from the rostral pons of multiple system atrophy patients
    Anna Jelaso Langerveld, Daniel Mihalko, Cari DeLong, Jeff Walburn, Charles F. Ide · 2007 · Movement Disorders
  51. Potential of cystamine and cysteamine in the treatment of neurodegenerative diseases
    Claire Gibrat, Francesca Cicchetti · 2010 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  52. α-Synuclein in Extracellular Vesicles: Functional Implications and Diagnostic Opportunities
    Camilla Lööv, Clemens R. Scherzer, Bradley T. Hyman, Xandra O. Breakefield, Martin Ingelsson · 2016 · Cellular and Molecular Neurobiology
  53. Vitamin K2 suppresses rotenone-induced microglial activation in vitro
    Yanxia Yu, Yi-pei Li, Feng Gao, Qingsong Hu, Yan Zhang, Dong Chen, Guanghui Wang · 2016 · Acta Pharmacologica Sinica
  54. Neuroinflammation in Parkinson’s Disease: Triggers, Mechanisms, and Immunotherapies
    Tai Wang, Changhe Shi, Haiyang Luo, Huimin Zheng, Liyuan Fan, Mibo Tang, Yun Su, Jing Yang, Chengyuan Mao, Yuming Xu · 2021 · The Neuroscientist
  55. Ganoderma lucidumProtects Dopaminergic Neuron Degeneration through Inhibition of Microglial Activation
    Ruiping Zhang, Shengli Xu, Yanning Cai, Ming Zhou, Xiaohong Zuo, Piu Chan · 2009 · Evidence-based Complementary and Alternative Medicine
  56. Functional Aspects of Redox Control During Neuroinflammation
    Sergio Rosales‐Corral, Russel Joseph Reiter, Dun‐Xian Tan, Genaro G. Ortiz, Gabriela del Carmen López-Armas · 2009 · Antioxidants and Redox Signaling
  57. Toll-Like Receptor 2 Signaling and Current Approaches for Therapeutic Modulation in Synucleinopathies
    Ian F. Caplan, Kathleen A. Maguire‐Zeiss · 2018 · Frontiers in Pharmacology
  58. α-Synuclein-carrying astrocytic extracellular vesicles in Parkinson pathogenesis and diagnosis
    Pan Wang, Guoyu Lan, Bin Xu, Zhenwei Yu, Chen Tian, Xia Lei, Wassilios G. Meissner, Tao Feng, Ying Yang, Jing Zhang · 2023 · Translational Neurodegeneration
  59. Pesticides, Microglial NOX2, and Parkinson's Disease
    Thomas Taetzsch, Michelle L. Block · 2013 · Journal of Biochemical and Molecular Toxicology
  60. What’s to like about the prion-like hypothesis for the spreading of aggregated α-synuclein in Parkinson disease?
    Christopher J.R. Dunning, Sonia George, Patrik Brundin · 2013 · Prion
  61. Connexin 43 hemichannels and pannexin‐1 channels contribute to the α‐synuclein‐induced dysfunction and death of astrocytes
    Esteban F. Díaz, Valeria C. Labra, Tanhia F. Alvear, Luis A. Mellado, Carla A. Inostroza, Juan Esteban Oyarzún, Nicole Salgado, Rodrigo A. Quintanilla, Juan Andres Orellana · 2019 · Glia
  62. The multiple roles of exosomes in Parkinson's disease: an overview
    Chiara Porro, Maria Antonietta Panaro, Dario Domenico Lofrumento, Elona Hasalla, Teresa Trotta · 2019 · Immunopharmacology and Immunotoxicology
  63. Microglia and Parkinson's disease: footprints to pathology
    Ekaterina Lazdon, Nofar Stolero, Dan Frenkel · 2020 · Journal of Neural Transmission
  64. α-Bisabolol, a Dietary Bioactive Phytochemical Attenuates Dopaminergic Neurodegeneration through Modulation of Oxidative Stress, Neuroinflammation and Apoptosis in Rotenone-Induced Rat Model of Parkinson’s Disease
    Hayate Javed, Mohamed Fizur Nagoor Meeran, Sheikh Azimullah, Lujain Bader Eddin, Vivek Dhar Dwivedi, Niraj Kumar Jha, Shreesh Kumar Ojha · 2020 · Biomolecules
  65. Blood–brain barrier (BBB)-on-a-chip: a promising breakthrough in brain disease research
    Bo Peng, Shiping Hao, Ziqiu Tong, Hua Bai, Sijun Pan, Kah‐Leong Lim, Lin Li, Nicolas Hans Voelcker, Wei Huang · 2022 · Lab on a Chip
  66. Glycometabolic Reprogramming of Microglia in Neurodegenerative Diseases: Insights from Neuroinflammation
    Huang, Qi, Wang, Yanfu, Chen, Shanshan, Liang, Fengxia · 2023 · Aging and disease
  67. Role of Toll-like receptor/MYD88 signaling in neurodegenerative diseases
    Xiang, Wang, Chao, Zhang-Yong, Feng, Du-Yi · 2015 · Reviews in the Neurosciences
  68. Suppressed pro-inflammatory response of microglia in CX3CR1 knockout mice
    Hayley A. Mattison, Hui Nie, Hui‐Ming Gao, Hui Zhou, Jau‐Shyong Hong, Jing Zhang · 2013 · Journal of Neuroimmunology
  69. Granulocyte–macrophage colony‐stimulating factor promotes survival of dopaminergic neurons in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced murine Parkinson’s disease model
    Na K. Kim, Byung Hyune Choi, Xian Huang, Brian Snyder, Shefqat Bukhari, TaeHo Kong, Hyeonseon Park, Hyung C. Park, So R. Park, Yoon Soo Ha · 2009 · European Journal of Neuroscience
  70. Combination therapies: The next logical Step for the treatment of synucleinopathies?
    Elvira Valera, Eliezer Masliah · 2015 · Movement Disorders
  71. Alpha-Synuclein in the Regulation of Brain Endothelial and Perivascular Cells: Gaps and Future Perspectives
    Tizibt Ashine Bogale, Gaia Faustini, Francesca Longhena, Stefania Maria Filomena Mitola, Marina Pizzi, Arianna Bellucci · 2021 · Frontiers in Immunology
  72. α‐Synuclein induces migration of BV‐2 microglial cells by up‐regulation of CD44 and MT1‐MMP
    Seonghan Kim, Seo‐Hyun Cho, Ka Young Kim, Ki Young Shin, Hye‐Sun Kim, Cheol‐Hyoung Park, Keun‐A Chang, Sang Hyung Lee, Daeho Cho, Yoo‐Hun Suh · 2009 · Journal of Neurochemistry
  73. Valproic Acid Neuroprotection in the 6-OHDA Model of Parkinson’s Disease Is Possibly Related to Its Anti-Inflammatory and HDAC Inhibitory Properties
    José Christian Machado Ximenes, Kelly Rose Tavares Neves, Luzia Kalyne Almeida Moreira Leal, Marta Regina Santos do Carmo, Gerly Anne de Castro Brito, Maria da Graça Naffah‐Mazzacoratti, Ésper A. Cavalheiro, Glauce Socorro de Barros Viana · 2015 · Journal of Neurodegenerative Diseases
  74. ER Stress Induced by Tunicamycin Triggers α-Synuclein Oligomerization, Dopaminergic Neurons Death and Locomotor Impairment: a New Model of Parkinson’s Disease
    Valentín Cóppola-Segovia, Clarissa F. Cavarsan, Flavia Gulak Maia, Anete Curte Ferraz, Lia S. Nakao, Marcelo MS Lima, Sílvio Marques Zanata · 2016 · Molecular Neurobiology
  75. A Novel Microfluidic Cell Co-culture Platform for the Study of the Molecular Mechanisms of Parkinson's Disease and Other Synucleinopathies
    João Tiago S. Fernandes, Oldriska Chutna, Virginia Chu, João Pedro Conde, Tiago F. Outeiro · 2016 · Frontiers in Neuroscience
  76. Manganese exposure exacerbates progressive motor deficits and neurodegeneration in the MitoPark mouse model of Parkinson’s disease: Relevance to gene and environment interactions in metal neurotoxicity
    Monica Renee Langley, Shivani Ghaisas, Muhammet Ay, Jie Denny Luo, Bharathi N. Palanisamy, Huajun Jin, Vellareddy Anantharam, Arthi Kanthasamy, Anumantha G. Kanthasamy · 2017 · NeuroToxicology
  77. miR-let-7a suppresses α-Synuclein-induced microglia inflammation through targeting STAT3 in Parkinson's disease
    Jianzhong Zhang, Dongwei Zhou, Zuopeng Zhang, Xin-Hui Qu, Kunwang Bao, Guohui Lu, Jian Duan · 2019 · Biochemical and Biophysical Research Communications
  78. Impact of α-synuclein pathology on transplanted hESC-derived dopaminergic neurons in a humanized α-synuclein rat model of PD
    Deirdre B. Hoban, Shelby Shrigley, Bengt Mattsson, Ludivine S. Breger, Ulla Jarl, Tiago Cardoso, Jenny Nelander Wahlestedt, Kelvin C. Luk, Anders Björklund, Malin Parmar · 2020 · Proceedings of the National Academy of Sciences
  79. P2Y6 and P2X7 Receptor Antagonism Exerts Neuroprotective/ Neuroregenerative Effects in an Animal Model of Parkinson’s Disease
    Oliveira-Giacomelli, Ágatha, M. Albino, Carolina, de Souza, Hellio Danny Nóbrega, Corrêa-Velloso, Juliana, de Jesus Santos, Ana Paula, Baranova, Juliana, Ulrich, Henning · 2019 · Frontiers in Cellular Neuroscience
  80. Microglial Phenotypes and Their Relationship to the Cannabinoid System: Therapeutic Implications for Parkinson’s Disease
    Rachel L. Kelly, Valerie L. Joers, Malú G. Tansey, Declan Patrick McKernan, Eilís Dowd · 2020 · Molecules
  81. Herpes simplex virus 1 accelerates the progression of Alzheimer’s disease by modulating microglial phagocytosis and activating NLRP3 pathway
    Wang, Zhimeng, Liu, Jing, Han, Jing, Zhang, Tianyi, Li, Shangjin, Hou, Yanfei, Su, Huili, Han, Fangping, Zhang, Conggang · 2024 · Journal of Neuroinflammation
  82. Artesunate activates Nrf2 pathway-driven anti-inflammatory potential through ERK signaling in microglial BV2 cells
    Ik‐Soo Lee, Dae-Kwang Ryu, Juhee Lim, Sera Cho, Bok Yun Kang, Hyun Jin Choi · 2011 · Neuroscience Letters
  83. Microglial NADPH oxidase activation mediates rod cell death in the retinal degeneration in rd mice
    Hui Zeng, Min Ding, X.-X. Chen, Qingjun Lu · 2014 · Neuroscience
  84. Age-Dependent Changes in the Activation and Regulation of Microglia
    Francisca Cornejo, Rommy von Bernhardi M. · 2016 · Advances in experimental medicine and biology
  85. Mechanisms of Parkinson’s disease-related proteins in mediating secondary brain damage after cerebral ischemia
    TaeHee Kim, Raghu Vemuganti · 2017 · Journal of Cerebral Blood Flow & Metabolism
  86. Alpha synuclein in hematopoiesis and immunity
    Yu Pei, Robert W. Maitta · 2019 · Heliyon
  87. Transcranial Ultrasound Stimulation Suppresses Neuroinflammation in a Chronic Mouse Model of Parkinson's Disease
    Hui Zhou, Long Meng, Xiangxiang Xia, Zhengrong Lin, Wei Zhou, Na Pang, Tianyuan Bian, Tifei Yuan, Lili Niu, Hairong Zheng · 2021 · IEEE Transactions on Biomedical Engineering
  88. Activated endothelial cells induce a distinct type of astrocytic reactivity
    Xavier Taylor, Pablo Cisternas, Nur Jury, Pablo Martínez, Xiaoqing Huang, Yanwen You, Javier Redding‐Ochoa, Rubén Vidal, Jie Zhang, Juan Carlos Troncoso et al. · 2022 · Communications Biology
  89. Neurodegenerative diseases and catechins: (−)-epigallocatechin-3-gallate is a modulator of chronic neuroinflammation and oxidative stress
    Siying Li, Zaoyi Wang, Gang Liu, Meixia Chen · 2024 · Frontiers in Nutrition
  90. Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
    Francesca L’Episcopo, Cataldo Tirolo, Salvatore Caniglia, Nunzio Testa, Pier Andrea Serra, Francesco Impagnatiello, Maria C. Morale, Bianca Marchetti · 2010 · Journal of Neuroinflammation
  91. Death in the substantia nigra: a motor tragedy
    Ennio Esposito, Vincenzo Di Matteo, Giuseppe Di Giovanni · 2007 · Expert Review of Neurotherapeutics
  92. Microglial glutamate release evoked by α‐synuclein aggregates is prevented by dopamine
    Maurício dos Santos Pereira, Leonardo Acuña, Sabah Hamadat, Jérémy Rocca, Florencia González‐Lizárraga, Rosana Nieves Chehín, Julia Elisa Sepulveda-Diaz, Elaine Aparecida Del Bel, Rita Raisman‐Vozari, Patrick Pierre Michel · 2018 · Glia
  93. The Peripheral Inflammatory Response to Alpha-Synuclein and Endotoxin in Parkinson's Disease
    Alice J. White, Ruwani Wijeyekoon, Kirsten M. Scott, Nushan P Gunawardana, Shaista Hayat, Imtiaz H. Solim, Harvey T. McMahon, Roger A. Barker, Caroline H. Williams‐Gray · 2018 · Frontiers in Neurology
  94. Food‐Origin Mycotoxin‐Induced Neurotoxicity: Intend to Break the Rules of Neuroglia Cells
    Xingyao Pei, Wenjuan Zhang, Haiyang Jiang, Dingkuo Liu, Xinyu Liu, Liuan Li, Cun Li, Xilong Xiao, Shusheng Tang, Daowen Li · 2021 · Oxidative Medicine and Cellular Longevity
  95. Mechanisms of Alpha-Synuclein Action on Neurotransmission: Cell-Autonomous and Non-Cell Autonomous Role
    Marco Emanuele, Evelina Chieregatti · 2015 · Biomolecules
  96. Role of Specialized Pro-resolving Mediators in Reducing Neuroinflammation in Neurodegenerative Disorders
    Jana Ponce, Arzu Ulu, Corrine Hanson, Erin Cameron‐Smith, John M. Bertoni, Jenna Wuebker, Alfred L. Fisher, Ka‐Chun Siu, Vivien Marmelat, Jiří Adamec et al. · 2022 · Frontiers in Aging Neuroscience
  97. Rapid macropinocytic transfer of α-synuclein to lysosomes
    Bayati, Armin, Banks, Emily, Han, Chanshuai, Luo, Wen, Reintsch, Wolfgang E., Zorca, Cornelia E., Shlaifer, Irina, Del Cid Pellitero, Esther, Vanderperre, Benoit, McBride, Heidi M. et al. · 2022 · Cell Reports
  98. Vitamin D as a Potential Therapy in Amyotrophic Lateral Sclerosis
    Alexandro Gianforcaro, Mazen Jamal Hamadeh · 2014 · CNS Neuroscience & Therapeutics
  99. Model fusion: The next phase in developing animal models for parkinson’s disease
    Amy Manning-Bog, J. William Langston · 2007 · Neurotoxicity Research
  100. Role of Glia in the Regulation of Sleep in Health and Disease
    Stefano Garofalo, Katherine Picard, Cristina Limatola, Agnès Nadjar, Olivier Pascual, Marie‐Ève Tremblay · 2020 · Comprehensive physiology